PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
Autor: | R. M. Magdeev, Ya. P. Dovgalevskiy, O.V. Reshetko, N. V. Furman |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
lcsh:Diseases of the circulatory (Cardiovascular) system st-elevation myocardial infarction pharmacoepidemiology RM1-950 реперфузионная терапия Reperfusion therapy St elevation myocardial infarction инфаркт миокарда с подъемом сегмента ST medicine Diseases of the circulatory (Cardiovascular) system Pharmacology (medical) cardiovascular diseases Myocardial infarction Intensive care medicine reperfusion therapy фармакоэпидемиология business.industry lcsh:RM1-950 Pharmacoepidemiology medicine.disease humanities Hospital treatment lcsh:Therapeutics. Pharmacology lcsh:RC666-701 RC666-701 Emergency medicine Therapeutics. Pharmacology Cardiology and Cardiovascular Medicine business |
Zdroj: | Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 5, Iss 6, Pp 7-12 (2016) |
ISSN: | 2225-3653 1819-6446 |
Popis: | Aim. To evaluate the real practice of thrombolytic therapy of patients with ST-elevation myocardial infarction (STEMI) at cardiological departments of Saratov and Saratov region hospitals.Material and methods. Retrospective pharmacoepidemiologic study was carried out. Case histories of STEMI patients discharged from cardiologic departments of several central district hospitals (CDH) of Saratov region, cardiologic department of one of Saratov general municipal hospitals (MH) and urgent cardiology department of Saratov clinical hospital (CH) in 2006 were analyzed.Results. In CH all patients received thrombolytic therapy given they did not have contraindications and were admitted to the hospital timely. Few patients received thrombolytic therapy in MH and CDH in 2006.Conclusion. Correlation between hospital type and quality of STEMI management has been revealed. |
Databáze: | OpenAIRE |
Externí odkaz: |